Clinical Outcomes after Proton Partial-Breast Radiotherapy for Early-Stage, Hormone Receptor-Positive Breast Cancer: 3-Year Outcomes of a Phase II Trial

被引:3
|
作者
Choi, I. J. [1 ]
Prabhu, K., Jr. [2 ]
Hartsell, W. F. [3 ]
Sinesi, C. C. [4 ]
Vargas, C. E. [5 ,6 ]
Benda, R. K. [7 ]
Cahlon, O. [8 ]
Chang, A. L. [9 ]
机构
[1] New York Proton Ctr, New York, NY USA
[2] Procure Proton Therapy Ctr, Oklahoma City, OK USA
[3] Northwestern Med Chicago Proton Ctr, Warrenville, IL USA
[4] Hampton Univ, Proton Therapy Inst, Hampton, VA 23668 USA
[5] Mayo Clin, Scottsdale, AZ USA
[6] Mayo Clin Arizona, Dept Radiat Oncol, Phoenix, AZ USA
[7] Boca Raton Reg Hosp, Boca Raton, FL USA
[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[9] Calif Protons Canc Therapy Ctr, San Diego, CA USA
关键词
D O I
10.1016/j.ijrobp.2019.06.659
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2042
引用
收藏
页码:E19 / E19
页数:1
相关论文
共 50 条
  • [1] Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial
    Choi, Isabelle
    Prabhu, Kiran
    Hartsell, William F.
    DeWees, Todd
    Sinesi, Christopher
    Vargas, Carlos
    Benda, Rashmi K.
    Cahlon, Oren
    Chang, Andrew L.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 37 : 71 - 77
  • [2] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Nayyar, Apoorve
    Strassle, Paula D.
    Iles, Kathleen
    Jameison, Danielle
    Jadi, Jihane
    McGuire, Kandace P.
    Gallagher, Kristalyn K.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (12) : 4853 - 4860
  • [3] Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women
    Apoorve Nayyar
    Paula D. Strassle
    Kathleen Iles
    Danielle Jameison
    Jihane Jadi
    Kandace P. McGuire
    Kristalyn K. Gallagher
    Annals of Surgical Oncology, 2020, 27 : 4853 - 4860
  • [4] Treatment of Early-Stage Hormone Receptor-Positive Breast Cancer
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 596 - 599
  • [5] Adjuvant Robotic Stereotactic Accelerated Partial Breast Irradiation (RSAPBI) for post-menopausal hormone receptor-positive early-stage breast cancer: 3-year outcomes of a prospective multi-institutional registry
    Marin, Monica Pernia
    Cantalino, Jonathan
    D'Ambrosio, David
    Hirsch, Arica
    Danner, Malika
    Rudra, Sonali
    Suy, Simeng
    Collins, Sean
    Matsanka, Dawn
    Good, Michael
    Feng, Jing
    Lamond, John
    Markiewicz, Deborah
    Lanciano, Rachelle
    Obayomi-Davies, Olusola
    Collins, Brian
    FUTURE ONCOLOGY, 2024, 20 : 12 - 13
  • [6] Checkpoint inhibition for early-stage hormone receptor-positive breast cancer
    Schlam, Ilana
    Corti, Chiara
    Sammons, Sarah
    Mittendorf, Elizabeth A.
    Tolaney, Sara M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) : 511 - 520
  • [7] Clinical outcomes and Oncotype DX Breast Recurrence Score (R) in early-stage BRCA-associated hormone receptor-positive breast cancer
    Layman, Rachel M.
    Lin, Heather
    Barrera, Angelica M. Gutierrez
    Karuturi, Meghan S.
    Yam, Clinton
    Arun, Banu K.
    CANCER MEDICINE, 2022, 11 (06): : 1474 - 1483
  • [8] Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer
    Carleton, Neil
    Zou, Jian
    Fang, Yusi
    Koscumb, Stephen E.
    Shah, Osama Shiraz
    Chen, Fangyuan
    Beriwal, Sushil
    Diego, Emilia J.
    Brufsky, Adam M.
    Oesterreich, Steffi
    Shapiro, Steven D.
    Ferris, Robert
    Emens, Leisha A.
    Tseng, George
    Marroquin, Oscar C.
    Lee, Adrian V.
    McAuliffe, Priscilla F.
    JAMA NETWORK OPEN, 2021, 4 (04)
  • [9] Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer
    O'Regan, Ruth M.
    Zhang, Yi
    Fleming, Gini F.
    Francis, Prudence A.
    Kammler, Roswitha
    Viale, Giuseppe
    Dell'Orto, Patrizia
    Lang, Istvan
    Bellet, Meritxell
    Bonnefoi, Herve R.
    Tondini, Carlo
    Villa, Federica
    Bernardo, Antonio
    Ciruelos, Eva M.
    Neven, Patrick
    Karlsson, Per
    Mueller, Bettina
    Jochum, Wolfram
    Zaman, Khalil
    Martino, Silvana
    Geyer, Charles E.
    Jerzak, Katarzyna J.
    Davidson, Nancy E.
    Coleman, Robert E.
    Ingle, James N.
    van Mackelenbergh, Marion T.
    Loi, Sherene
    Colleoni, Marco
    Schnabel, Catherine A.
    Treuner, Kai
    Regan, Meredith M.
    JAMA ONCOLOGY, 2024, 10 (10) : 1379 - 1389
  • [10] Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor-Positive Breast Cancer
    O'Regan, Ruth M.
    Zhang, Yi
    Fleming, Gini F.
    Francis, Prudence A.
    Kammler, Roswitha
    Viale, Giuseppe
    Dell'Orto, Patrizia
    Lang, Istvan
    Bellet, Meritxell
    Bonnefoi, Herve R.
    Tondini, Carlo
    Villa, Federica
    Bernardo, Antonio
    Ciruelos, Eva M.
    Neven, Patrick
    Karlsson, Per
    Mueller, Bettina
    Jochum, Wolfram
    Zaman, Khalil
    Martino, Silvana
    Geyer, Charles E.
    Jerzak, Katarzyna J.
    Davidson, Nancy E.
    Coleman, Robert E.
    Ingle, James N.
    van Mackelenbergh, Marion T.
    Loi, Sherene
    Colleoni, Marco
    Schnabel, Catherine A.
    Treuner, Kai
    Regan, Meredith M.
    JAMA ONCOLOGY, 2024, 10 (10) : 1379 - 1389